AQP4 and glioblastoma: Our earlier research demonstrated that targeting AQP4 has a great deal of potential for treating GBM, and it was the first study based on our knowledge to show that AQP4 restriction can considerably increase the responsiveness of GBM treatment with medications [12, 17].